STOCK TITAN

Analog Devices, Inc. Form 4 Filings

ADI NASDAQ

Every Form 4 that Analog Devices, Inc. (ADI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ADI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ADI filings page.

Rhea-AI Summary

Analog Devices Inc. director Karen Golz reported an equity award of 747 shares of common stock. The award represents her annual grant of Restricted Stock Units that were granted at no cash cost to her.

The RSUs vest 100% on the earlier of March 11, 2027 or the company’s next annual meeting of shareholders, after which each unit will convert into one share of common stock. Following this award, Golz is shown as directly holding 13,019 shares of Analog Devices common stock.

Rhea-AI Summary

Analog Devices Inc. director Frank Edward H. received an annual equity award in the form of 747 Restricted Stock Units (RSUs) on March 11, 2026. These RSUs vest 100% on the earlier of March 11, 2027 or the date of the company’s next annual meeting of shareholders, and each vested RSU will convert into one share of common stock.

After this award, he holds 5,865 shares of common stock directly. The filing also shows 3,000 shares held indirectly in each of two separate 2015 Heritage Trusts, providing additional indirect ownership context.

Rhea-AI Summary

Analog Devices director Ray Stata reported mixed insider activity involving company stock. He exercised a fully vested non-qualified stock option for 7,640 shares at $54.93 per share and received an equal number of common shares.

On the same date, he sold 1,226 common shares in an open-market transaction at $339.15 per share. After these transactions, he held 127,110 common shares directly and 652,221 common shares indirectly through his spouse.

Rhea-AI Summary

Analog Devices Chair and CEO Vincent Roche exercised options and sold shares in a planned transaction. On March 2, he exercised a non-qualified stock option for 10,000 shares at $94.41 per share, then sold 10,000 common shares at $350.00 per share under a Rule 10b5-1 trading plan adopted on May 23, 2025. After these moves, he directly owns 155,688.462 common shares and has an additional 23,515 shares held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust.

Rhea-AI Summary

Analog Devices chief accounting officer Michael Sondel reported an open-market sale of company stock. On February 25, he sold 4,198.95 shares of common stock at an average price of $361.025 per share. After this transaction, he directly held 14,739.579 shares of Analog Devices common stock.

Rhea-AI Summary

Analog Devices director Yoky Matsuoka reported an award of 97 restricted stock units (RSUs) tied to the company’s common stock. The RSUs vest 100% on the earlier of the company’s 2026 annual shareholder meeting or March 12, 2026. Upon vesting, each RSU converts into one share of Analog Devices common stock, giving the director 97 shares if the vesting conditions are met. The grant was reported as a direct, no-cost equity award rather than an open-market purchase.

Rhea-AI Summary

Analog Devices Inc. director Ray Stata reported a series of open-market sales of common stock on February 4 and 5, 2026, under a pre-arranged Rule 10b5-1 trading plan adopted on January 9, 2025. The reported transactions involved multiple small share blocks sold at weighted average prices ranging from about $312.695 to $326.585 per share.

Following these sales, Stata directly beneficially owns 120,696 shares of Analog Devices common stock and indirectly beneficially owns an additional 652,221 shares held "By Mrs. Stata Directly."

Rhea-AI Summary

Analog Devices Chair & CEO Vincent Roche reported option and share transactions on February 2, 2026. He exercised 10,000 non-qualified stock options at $94.41 per share, receiving 10,000 shares, then sold 10,000 shares of common stock at $306.92 per share under a pre-arranged 10b5-1 plan.

After these trades, Roche directly holds 155,688.462 Analog Devices common shares and 44,637 stock options. An additional 23,515 shares are held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024.

Rhea-AI Summary

Analog Devices director Ray Stata reported a series of open-market sales of common stock in mid-January 2026 under a pre-arranged trading plan. On January 13 and 14, 2026, he sold multiple blocks of Analog Devices common stock at weighted average prices ranging from $293.984 to $301.895 per share, as disclosed in separate transactions.

The sales were made pursuant to a Rule 10b5-1 trading plan adopted on January 9, 2025, which is designed to allow insiders to sell shares according to a preset schedule. Following these transactions, Stata beneficially owned 126,946 shares directly and an additional 652,221 shares indirectly reported as held "By Mrs. Stata Directly."

Rhea-AI Summary

Analog Devices SVP and Chief Customer Officer Nakamura Katsufumi reported a small stock sale in a Form 4 filing. On January 9, 2026, he sold 500 shares of Analog Devices common stock at a price of $301.465 per share. After this transaction, he directly owned 12,709.698 shares of Analog Devices common stock.

Rhea-AI Summary

Analog Devices SVP and Chief Customer Officer Nakamura Katsufumi reported an open-market sale of company stock. On January 7, 2026, Nakamura sold 500 shares of Analog Devices common stock at a price of $289.165 per share.

After this transaction, Nakamura beneficially owned 13,209.698 shares of Analog Devices common stock. This amount includes 25.838 shares acquired on December 5, 2025 under the Analog Devices, Inc. Amended & Restated 2022 Employee Stock Purchase Plan.

Rhea-AI Summary

Analog Devices executive Cotter Martin reported a stock sale. On January 5, 2026, Martin, who serves as SVP, Vertical Business Units at Analog Devices, Inc., sold 10,000 shares of the company’s common stock at a price of $278.445 per share.

After this transaction, Martin beneficially owned 49,663.684 shares of Analog Devices common stock in direct ownership. This filing is a routine disclosure of insider trading activity required under securities regulations and shows the updated share holdings of this senior officer.

Rhea-AI Summary

Analog Devices Inc. reported an insider stock transaction by a senior executive. On 12/17/2025, an officer serving as SVP, Vertical Business Units sold 5,000 shares of Analog Devices common stock at a price of $271.1901 per share. After this sale, the executive directly beneficially owned 59,663.684 shares. This total includes 25.838 shares that were acquired earlier under the Analog Devices, Inc. Amended & Restated 2022 Employee Stock Purchase Plan on 12/05/2025. The filing was made as a Form 4 for one reporting person, reflecting the change in this officer’s direct ownership position in Analog Devices stock.

Rhea-AI Summary

Analog Devices Inc. (ADI) disclosed that a company director reported multiple open-market sales of common stock on December 16 and 17, 2025. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 9, 2025. Reported weighted average sale prices included $278.4932 per share for 1,080 shares on December 16 and $270.9226 per share for 1,377 shares on December 17, with additional smaller sales at nearby prices.

After these transactions, the director beneficially owns 133,196 shares of Analog Devices common stock directly and 652,221 shares indirectly through a spouse noted as "By Mrs. Stata Directly." No derivative securities were reported as acquired or disposed of in this filing.

Rhea-AI Summary

Vincent Roche, Chair, CEO and Director of Analog Devices, exercised 10,000 non-qualified stock options for common stock at an exercise price of $94.41 per share on December 12, 2025. The options were fully vested and related to 10,000 shares of Analog Devices common stock.

On the same date, Roche sold 10,000 shares of Analog Devices common stock at $282.42 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 23, 2025. After these transactions, he directly held 155,688.462 common shares, an additional 23,515 shares were held indirectly through the Vincent Roche 2024 Grantor Retained Annuity Trust, and 64,637 non-qualified stock options remained beneficially owned.

Rhea-AI Summary

Analog Devices' chief accounting officer filed an amended insider transaction report for a stock sale on December 10, 2025. The report shows the sale of 8,169 shares of common stock at a corrected weighted average price of $279.4999 per share, executed through multiple trades.

The amendment revises an earlier report that had used a weighted average sale price of $278.0309 and updates the related price footnote. After these transactions, the officer directly beneficially owns 18,912.691 shares of Analog Devices stock.

Rhea-AI Summary

Analog Devices' chief accounting officer reported stock option exercises and a share sale dated 12/10/2025. The officer exercised non-qualified stock options to acquire 2,200 shares at $83.48, 1,992 shares at $91.13, and 3,977 shares at $108.08 of common stock.

The officer then sold 8,169 shares of common stock at a weighted average price of $278.0309 per share, with individual sale prices ranging from $279.437 to $249.615. After these transactions, the officer beneficially owns 18,912.691 shares of Analog Devices common stock directly.

Rhea-AI Summary

Analog Devices, Inc. (ADI) executive vice president of Global Operations reported an insider equity transaction. On November 17, 2025, the officer had 1,162.862 shares of common stock withheld in a transaction coded "F," which indicates shares were used to cover tax withholding related to equity awards. The explanation notes these shares were withheld in connection with the vesting of 2,290 restricted stock units on the same date, meaning part of the award was retained by the company to satisfy tax obligations. After this transaction, the officer beneficially owned 44,818.124 shares of Analog Devices common stock directly.

Rhea-AI Summary

Analog Devices (ADI): Form 4 insider transaction — A company director reported open‑market sales totaling 6,250 shares on 11/04/2025 and 11/05/2025 under a Rule 10b5‑1 trading plan adopted on January 9, 2025. The trades were executed in multiple transactions at weighted average prices, with underlying sale price ranges from $228.87 to $238.435 per share. Following these transactions, the director beneficially owns 139,446 shares directly and 652,221 shares indirectly.

Rhea-AI Summary

Analog Devices (ADI) Form 4: Chair & CEO Vincent Roche exercised 10,000 non-qualified stock options at $94.41 per share on 11/03/2025 and sold 10,000 common shares the same day at $234.95 per share pursuant to a 10b5-1 plan adopted on May 23, 2025.

After these transactions, he reported 163,640.462 shares held directly. He also reports 23,515 shares held indirectly by the Vincent Roche 2024 Grantor Retained Annuity Trust dated October 3, 2024. Following the option exercise, 74,637 options remain beneficially owned. The exercised option was fully vested, originally exercisable from 03/15/2021 and expiring on 03/11/2030.

Rhea-AI Summary

Vincent Roche, Chair & CEO of Analog Devices, Inc. (ADI), reported changes in his beneficial ownership on 10/07/2025. Upon termination of the 2023 GRAT, 11,306 shares were transferred to an independent 2023 Irrevocable Trust in which he has no pecuniary interest, while 23,522 shares were disbursed from the 2023 GRAT to Mr. Roche to satisfy the trust's annuity obligation. The filing also shows 163,640.462 shares held in the 2023 GRAT prior to the transfers and 23,515 shares held in the 2024 GRAT. The Form 4 was signed by General Counsel by power of attorney on 10/08/2025.

Rhea-AI Summary

Insider sale by a director: A director, Frank Edward H., reported a sale of 1,000 shares of Analog Devices Inc. common stock on 10/06/2025 at a price of $242.7401 per share. After the sale, the reporting person holds 5,118 shares directly and an additional 3,000 shares indirectly through the Frank 2015 Heritage Trust and Whitton Anne Frank 2015 Heritage Trust, for a total reported beneficial position of 8,118 shares.